Shares of Neuronetics Inc. (STIM) are soaring in pre-market today, after the medical technology company announced that the FDA has recently granted Breakthrough Device Designation for the company's NeuroStar Advanced Therapy System for the treatment of bipolar depression.
from RTT - Before the Bell https://ift.tt/2VS2wgm
via IFTTT
No comments:
Post a Comment